[ccpw id="5"]

Home.forex news reportAnalyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results

Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results

-


Outset Medical, Inc. (NASDAQ:OM) is one of the 7 most volatile stocks under $5 for day trading.

Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results
Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results

On February 12, 2026, Outset Medical, Inc. (NASDAQ:OM) shares received fresh support from analysts despite a decline in price targets after fourth-quarter results that largely met expectations. After the company provided what it considered to be a realistic 2026 target, TD Cowen lowered its target to $12 from $15, and BTIG lowered its target to $15 from $17, both of which kept their ‘Buy’ ratings.

In a research note, the BTIG analyst informed investors that this quarter, featuring a stable sales force, an upcoming product, a wide and expanding deal pipeline, robust recurring revenue, and improving margins, will help the company restore credibility.

Outset Medical, Inc. (NASDAQ:OM), on February 11, 2026, announced fourth-quarter revenue of $28.90 million, a 2% year-over-year decrease. Accordingly, the total revenue for 2025 came out at $119.50 million, a 5% increase. In addition, the full-year margin improved to 39.10%, and the quarterly gross margin increased by 600 basis points to 42.40%.

Meanwhile, cash at year-end was $173 million, and adjusted net loss decreased from $19.30 million to $15.10 million. In addition to outlining plans to launch its next-generation Tablo platform in the second quarter, Outset Medical, Inc. (NASDAQ:OM)’s management projected 2026 revenue of $125 million to $130 million, with a non-GAAP gross margin in the low-to-mid-40% range.

Outset Medical, Inc. (NASDAQ:OM), founded in 2003 in San Jose, offers dialysis solutions through its Tablo Hemodialysis System, which enables both acute and home treatment. The company aims to simplify and modernize dialysis care delivery.

While we acknowledge the potential of OM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: What Are the Best Stocks to Buy Right Now? and 10 Stocks Under $1 That Will Explode.

Disclosure: None.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

W.W. Grainger (GWW) Gets Price Target Increase from JPMorgan Following Earnings Update

W.W. Grainger, Inc. (NYSE:GWW) is included among the 16 Best Dividend Stocks with Rising Payouts. ...

FDVV Takes No. 1 Spot

Top 10 Creations (All ETFs) Ticker Name Net Flows ($, mm) AUM ($, mm)...

Soybeans Slip Lower on Friday Following Supreme Court Ruling

Soybeans were down 3 to 4 cents in the front months, as Marc was up 4 ½ cents this week. The...

Microsoft Gaming head Phil Spencer retires, insider Asha Sharma takes over

By Jaspreet Singh Feb 20 (Reuters) - Microsoft said on Friday gaming head Phil Spencer is retiring after 38...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img